Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)

HKG:2637 Revenue

Fujian Haixi Pharmaceuticals had revenue of 155.81M CNY in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to 593.90M. In the year 2025, Fujian Haixi Pharmaceuticals had annual revenue of 582.36M with 24.79% growth. That makes Fujian Haixi Pharmaceuticals the 23,731st largest company in the world by revenue and 1,405th in Hong Kong.

• Revenue (ttm): 593.90M CNY
• Revenue Growth: +24.79%
• P/S Ratio: 17.47
• Revenue / Employee: 2.97M CNY
• Employees: 200
• Market Cap: 11.98B HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	582.36M	115.68M	24.79%
Dec 31, 2024	466.68M	150.05M	47.39%
Dec 31, 2023	316.63M	104.17M	49.03%
Dec 31, 2022	212.47M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 3, 2026

Data Sources Report a data error